The Lack of HER-2/neu Oncogene Amplification in Colorectal Malignancies [5] (multiple letters)

Gastroenterology

Volumn 125, Issue 6, 2003, Pages 1915-1916

  Pedowitz, Shauna D ^b   Matulewicz, Theodore ^b   Croft, Christina ^b   Rudolph, Hollie ^b   Strada, David ^b   Keifer, Judith A ^b   Topilow, Arthur A ^b   Potti, Anil ^a  

^a UND School of Medicine & Health Sciences Southeast Campus   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CANCER STAGING; CANCER SURVIVAL; COLORECTAL CANCER; FEMALE; GENE AMPLIFICATION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LETTER; MAJOR CLINICAL STUDY; MALE; ONCOGENE NEU; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM;

EID: 0344197098     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2003.04.016     Document Type: Letter

References (7)

1. V. Devita S. Hellman S. Rosenberg Cancer Principles and Practice of Oncology 2 2001 1645 1646
2. M. Mann H. Sheng J. Shao Targeting cyclooxygenase 2 and HER-2/neu pathways inhibits colorectal cancer growth Gastroenterology 120 2001 1713 1719
3. N. Gill A. Malik A. Potti R. Talukdar HER-2/neu overexpression in colonic malignancies (letter) Gastroenterology 122 2002 248 249
4. B. Strachan-Kiner X. Qiao P. Savargaonkar Correlation between HER-2/neu positivity and clinical stage of colorectal cancers Am Soc Clin Oncol abstr 2002 2968
5. M.X. Slikowski R.N. Dubois HER-2/neu overexpression in colonic malignancies (letter) Gastroenterology 122 2002 248 252
6. A. Rhodes B. Jasani E. Anderson Evaluation of HER-2/neu immunohistochemical assay sensitivity and scoring on formalin-fixed and paraffin-processed cell lines and breast tumors a comparative study involving results from laboratories in 21 countries Am J Clin Pathol 118 2002 408 417
7. S.L. Taylor P.S. Rudland R. Barraclough C-erbB-2 mRNA in breast cancer specimens that exhibit membrane or cytoplasmic immunoreactivity for c-erbB-2 Oncol Res 11 1999 311 317